0001230245false00012302452024-09-232024-09-23

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ________________________________
FORM 8-K
 _________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

September 23, 2024
Date of report (Date of earliest event reported)
_________________________________ 
PIPER SANDLER COMPANIES
(Exact Name of Registrant as Specified in its Charter)
_________________________________ 
Delaware1-3172030-0168701
(State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
800 Nicollet MallSuite 900
MinneapolisMinnesota55402
(Address of Principal Executive Offices)(Zip Code)
(612)303-6000
(Registrant’s Telephone Number, Including Area Code)
 _________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading SymbolName of Each Exchange On Which Registered
Common Stock, par value $0.01 per sharePIPRThe New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐




Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective as of September 23, 2024, upon the recommendation of the Nominating and Governance Committee of the Board of Directors (the “Board”) of Piper Sandler Companies (the “Company”), the Board elected Ann C. Gallo to serve as a director of the Company for an initial term expiring at the Company’s 2025 annual meeting of shareholders. Following Ms. Gallo’s election to the Board, the size of the Company’s Board increased by one, from ten to eleven directors.

Ms. Gallo was formerly a senior managing director, partner, and investment team leader for the healthcare team at Wellington Management Company, LLP, a global investment firm.

Ms. Gallo has not been appointed to serve on any committee of the Board and the committees on which Ms. Gallo is expected to serve have not been determined as of the date of filing of this Current Report on Form 8-K. The Board expects to determine the committees to which Ms. Gallo will be appointed in February 2025.

In connection with her service on the Board, Ms. Gallo will participate in the Company’s 2024 non-employee director compensation program, receiving a pro-rated $100,000 annual cash retainer, a $60,000 initial equity grant and a pro-rated $100,000 annual equity grant.

There are no arrangements or understandings between Ms. Gallo and any other persons pursuant to which Ms. Gallo was selected as a director of the Company. Ms. Gallo has not engaged in any related person transactions (as defined in Item 404(a) of Regulation S-K) with the Company.

Item 7.01.    Regulation FD Disclosure.

On September 23, 2024, the Company issued a press release announcing the event discussed in Item 5.02 above, the text of which is furnished as Exhibit 99 hereto. The information contained in this Item 7.01 and Exhibit 99 is being furnished, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under Section 18 of the Exchange Act. Furthermore, the information contained in this Item 7.01 and Exhibit 99 shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits.
99
104
Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document).




SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

PIPER SANDLER COMPANIES
Date: September 23, 2024By/s/ John W. Geelan
John W. Geelan
General Counsel and Secretary



Exhibit 99


image.jpg
Piper Sandler Companies
800 Nicollet Mall, Suite 1000
Minneapolis, MN 55402

CONTACT
Kate Clune
Chief Financial Officer
Tel: 212 466-7799
investorrelations@psc.com
FOR IMMEDIATE RELEASE



Piper Sandler Companies Elects Ann Gallo to
Board of Directors

MINNEAPOLIS – September 23, 2024 – Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Ann Gallo to its board of directors.

Most recently, Gallo was a senior managing director and partner at Wellington Management Company, LLP, as well as the investment team leader of Wellington’s healthcare team, which managed over $60 billion in assets during her tenure. As a healthcare industry analyst and portfolio manager, Gallo researched healthcare services and medical technology companies and served as portfolio manager for multiple diversified long-only and long-short strategies. She was also a founding member and healthcare portfolio manager of Wellington’s dedicated private equity franchise. During her 25 years at Wellington, Gallo served on numerous fiduciary committees, including Operating, Governance, Hedge Fund Review, and Private Equity Oversight. Prior to joining Wellington in 1998, Gallo was a senior healthcare analyst with Alex. Brown & Sons (1995 to 1998), and was in investment banking and a healthcare research analyst at Piper Sandler (1992 to 1995).

“Ann will be a great asset to our board of directors with her breadth of knowledge in the healthcare space, a key sector for our investment banking, public finance and research businesses at Piper Sandler,” said Chad Abraham, Piper Sandler chairman and chief executive officer. “Her experience as a leading healthcare analyst and extensive financial services leadership will provide us with another valuable perspective on the board.”

Gallo earned a bachelor’s degree in accounting from Boston College and a master’s degree in finance and applied economics from Massachusetts Institute of Technology.

About Piper Sandler
Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, authorized and regulated by BaFin as a tied agent of AHP Capital Management GmbH; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.



____________________________________________________________________________________________________________________________________________

Follow Piper Sandler: LinkedIn | Facebook | X

©2024. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

v3.24.3
Cover Page Document
Sep. 23, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Sep. 23, 2024
Entity Registrant Name PIPER SANDLER COMPANIES
Entity Incorporation, State or Country Code DE
Entity File Number 1-31720
Entity Tax Identification Number 30-0168701
Entity Address, Address Line One 800 Nicollet Mall
Entity Address, Address Line Two Suite 900
Entity Address, City or Town Minneapolis
Entity Address, State or Province MN
Entity Address, Postal Zip Code 55402
City Area Code (612)
Local Phone Number 303-6000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol PIPR
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0001230245
Amendment Flag false
Piper Sandler Companies (NYSE:PIPR)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos Piper Sandler Companies.
Piper Sandler Companies (NYSE:PIPR)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos Piper Sandler Companies.